Every 10-Q that MEDWELLAI INC (MWAI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MWAI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MWAI filings page.
MedWellAI, Inc. reported a quarterly net loss attributable to shareholders of $240,237 and a nine‑month loss of $1,179,634 for the period ended March 31, 2026, as it continues to transition into AI‑driven healthcare and wellness.
Total revenue rose to $618,676 for the quarter and $1,694,482 for nine months, driven mainly by GLP medication product sales of $596,176 for the quarter and $1,622,679 year‑to‑date, plus rental income.
Despite this growth, the company had cash of $130,028, current liabilities of $7,777,135, and an accumulated deficit of $89,853,514, leading management to state there is substantial doubt about its ability to continue as a going concern.
MedWellAI, Inc. reports sharply higher revenue but continues to operate at a loss with serious liquidity pressure. For the six months ended December 31, 2025, revenue rose to $1,075,806 from $144,009 a year earlier, driven mainly by GLP medication product sales and new rental income.
Despite this growth, MedWellAI recorded a net loss attributable to shareholders of $939,397, though this improved from a $1,889,958 loss in the prior-year period. Cash was only $137,503 against current liabilities of $7,678,166, resulting in a working capital deficit of $7,513,736 and an accumulated deficit of $89,613,277.
The company has exited digital asset mining, pivoting to AI-driven healthcare and wellness through pharmaceutical product distribution and health-focused real estate. Management discloses that these recurring losses and the large deficit raise substantial doubt about its ability to continue as a going concern without new debt or equity financing.
MedWellAI, Inc. (MWAI) filed its quarterly report and reported a shift toward commission-based health and wellness distribution while posting a smaller loss. Revenue was $96,094 for the quarter ended September 30, 2025, up from $1,148 a year ago, driven mainly by $94,887 of commissions. Net loss attributable to shareholders was $651,878 versus $1,216,047 last year.
Liquidity remains tight. Cash was $223,221; current liabilities were $7,534,367, resulting in a working capital deficit of $7,292,726. The company disclosed substantial doubt about its ability to continue as a going concern. A share exchange consolidated prior Series C and D preferred into 6,500 Series C Convertible Preferred shares, recorded as a current liability of $6,500,000; the move retired $2,133,081 of accrued dividends and resulted in a $241,918 loss. One $500,000 note payable remains in default. Common shares outstanding were 6,236,580 as of November 10, 2025.